View More Recent Stories

Sep 20, 2024 08:56AM Viking Therapeutics (VKTX) ticks higher after Novo Nordisk's monlunabant obesity data
Sep 19, 2024 05:54AM Viking Therapeutics (VKTX) call put ratio 2.8 calls to 1 put with focus on September 28 calls
Sep 12, 2024 06:56AM Morgan Stanley Reiterates Overweight Rating on Viking Therapeutic (VKTX)
Sep 11, 2024 02:43AM JPMorgan Starts Viking Therapeutic (VKTX) at Overweight
Aug 27, 2024 01:37PM Truist Defending Viking Therapeutics (VKTX): 'recommend investors take advantage of today’s selloff to add to shares'
Aug 27, 2024 10:09AM Viking Therapeutics (VKTX) call put ratio 10.4 calls to 1 put after Eli Lilly & Co. (LLY) launches single-dose vials of Zepbound
Aug 20, 2024 02:16PM Viking Therapeutics (VKTX) September 80 and 90 calls active as share price down 5.4%
Aug 20, 2024 11:26AM Viking Therapeutics (VKTX) September 80 and 90 calls as share price down 6%
Aug 20, 2024 05:43AM Viking Therapeutics (VKTX) call put ratio 6.3 calls to 1 put with focus on September calls
Aug 19, 2024 03:39PM Viking Therapeutics (VKTX) Extends Gain, Climbs 17%
Aug 13, 2024 05:01AM Viking Therapeutics (VKTX) call put ratio 4 calls to 1 put with focus on August 23 weekly 66 and 69 calls
Aug 9, 2024 03:46AM Viking Therapeutics (VKTX) call put ratio 3.9 calls to 1 put with focus on November 70 calls
Jul 30, 2024 07:17AM RBC's biotech survey shows investors more bearish vs. last time
Jul 29, 2024 05:21AM Options with decreasing option implied volatility: GME VKTX TSLL ALGN QS ENPH SPOT HE HOG VRT
Jul 24, 2024 05:01PM After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more
Jul 24, 2024 04:33PM Viking Therapeutics (VKTX) to advance VK2735 into Phase 3 program for obesity
Jul 24, 2024 04:15PM Viking Therapeutics (VKTX) Tops Q2 EPS by 6c
Jul 23, 2024 11:14AM Viking Therapeutics (VKTX) call put ratio calls to 1 put with focus on August 65 calls
Jul 18, 2024 04:30AM Viking Therapeutics (VKTX) 30-day option implied volatility above 100 after Roche reports weight loss pill data
Jul 11, 2024 06:53AM Novo Nordisk (NVO), Others Decline After Pfizer (PFE) Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron
Jul 5, 2024 06:29AM BTIG Out Positive on Viking Therapeutic (VKTX), 'favorable catalyst set up for VKTX headed into 2H24'
Jun 28, 2024 10:23AM Viking Therapeutics (VKTX) 30-day option implied volatility is at 109; compared to its 52-week range of 51 to 234 as share price up 3.6% to $52.60. Call put ratio 14.3 calls to 1 put with focus on Jul
Jun 27, 2024 03:21AM Morgan Stanley Starts Viking Therapeutic (VKTX) at Overweight
Jun 25, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
Jun 24, 2024 07:33AM Viking Therapeutics (VKTX) Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists
Jun 20, 2024 11:57AM Viking Therapeutics (VKTX) option IV below 100
Jun 20, 2024 05:59AM Viking Therapeutics (VKTX) call put ratio 2.2 calls to 1 put on flat IV
Apr 2, 2024 10:00AM Here are Oppenheimer’s best Smidcap ideas
View More Recent Stories